Kidney Stones

  • Salvatore Rocca Rossetti
Chapter

Abstract

Much is known regarding the frequency, prevalence, geographic manifestation, phylogenesis, etiology, physiopathology, clinical presentation, and therapy of kidney stones. Crystalline concretions are present in the kidneys of vertebrates and the equivalent excretory organs of invertebrates; the calcium constitution of the endoskeleton and exoskeleton creates the finite turnover and excretion of calcium, water conservation, and consequent low volume of urine. Thus, it is very difficult to keep calcium salts and other solutes in the urine solution since the laws of physiochemistry cannot be altered via biological evolution. Substances that promote and inhibit the calcium solution are well established in human urine, and their quality and quantity are of great importance, both in physiopathology and in a clinical setting. Urolithiasis is present in 0.5 % of US and EU populations, but its prevalence has increased from 3.2 % to 5.2 % since the 1970s; bladder stones have decreased notably in the last 20 years in developed countries. Stone recurrence remains at 50 % over 5–10 years and 75 % over 20 years; recurrence increases the probability of relapse and increases the amount of time between the two recurrences. These data are very important for what we shall go on to demonstrate here.

References

  1. 1.
    Zizmv AR, Evan AP, Coe FL, Worcester EM. Do kidney stone formers have a kidney disease? Kidney Int. 2015;88:1240–9.CrossRefGoogle Scholar
  2. 2.
    Evan AP, Coe FL, Lingeman JE, et al. Mehanism of formation of human calcium oxalate stones on randall’s plaque. Anat Rec (Hoboken). 2007;290:1315–23.CrossRefGoogle Scholar
  3. 3.
    Evan AP, Lingeman JE, Coe FL, et al. Role of interatitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol. 2008;28:111–9.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Ingram CJE, Muller Yvalitan CA, Swallw MGT. Lactose digestion and evolutionary genetics of lactose persistence. Hum Genet. 2009;124:579–91.CrossRefPubMedGoogle Scholar
  5. 5.
    Rossetti SR. La Terapia della Calcolosi Urinaria. In: Conferenza VI Congresso Nazionale CLU, Srt, Torino; 2015.Google Scholar
  6. 6.
    Vent A, Guner MD. Helicobacter pylory and urinary system stones. Endoluminal damage as subhypothesis to support the current stone theory. Med Hypotheses. 2014;83(6):677–80.CrossRefGoogle Scholar
  7. 7.
    Stoller MI, Meng MI, Abramahams MH, Kane JP. The primary stone event: a new vascular etiology. J Urol. 2004;171:1920–4.CrossRefPubMedGoogle Scholar
  8. 8.
    Smith GM, Zwart SR, et al. Men and women in the space: bone loss and kidney risk after long duration spaceflight. J Bone Miner Res. 2024;29(6):1639–45.Google Scholar
  9. 9.
    Liskopoulos V. The kidney in the space. In: 6th international conference of aerospace medicine, Thessaloniki, Set; 2010.Google Scholar
  10. 10.
    Deng E, et al. Study of histopathological and molecular changes of rat kidney under simulated weightlessness and resistance training protective effect. PLoS One. 2011;6(5):e20008.CrossRefGoogle Scholar
  11. 11.
    Blaser MJ, Falow WS. What are the consequenses of the disappering human microbiota? Nat Rev Microbiol. 2009;7(12):857–94.CrossRefGoogle Scholar
  12. 12.
    Moe OO. Kidney stones: phatophysiology and medical menagement. Lancet. 2006;367:333–44.CrossRefPubMedGoogle Scholar
  13. 13.
    Khan SR, Canales BR. Unified theory on the pathogenesis of randall plaques and plugs. Urolithiasis. 2015;41(Suppl 11):109–23.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  • Salvatore Rocca Rossetti
    • 1
  1. 1.Urology DepartmentUniversity of TurinTurinItaly

Personalised recommendations